Reaction profile

The FDA adverse-event record for urinary tract neoplasm nos

Name: Urinary tract neoplasm NOS - FDA Animal Adverse Reaction
Creator: PlainBreed
License: https://open.fda.gov/license/

10 FDA reports name urinary tract neoplasm nos, a lower-volume reaction in the CVM extract (VeDDRA 742). Plate stamps and neighbourhood peers follow.

#2481 of 2,481
by report volume (all reactions): 10
reports citing this reaction: 30.0%
death-coded share: Dog
most-affected species

Compiled by PlainBreed

Verify with FDA CVM →

FDA AER · VeDDRA plate

Code 742 VOL-TRACE

VOL-TRACE · DEATH-HOT · BOTTOM-DECILE · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

VOL-TRACE 10 reports
DEATH-HOT 30.0%
BOTTOM-DECILE #2481/2481
PHOTO-FINISH Anoxia
SPECIES-DOG Dog · 10
DRUG-LEAD Bedinvetmab · 5
DESK-WIDE 9 breeds
BOOK-FULL 8/8 fields

Nearest volume peer: Anoxia (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around Urinary tract neoplasm NOS

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

FDA AER report volume · neighbourhood around Urinary tract neoplasm NOS

Urinary tract neoplasm NOS: high death-coded share in the FDA AER plate

Signature read: 10 reports place Urinary tract neoplasm NOS in the lower third of FDA AER volume (#2481 of 2,481). Report volume is lower-third scale: 10 named reports in the openFDA extract. Death-coded share is upper-third: 3 of 10 reports (30.0% of named reports). Nearest volume peer: Anoxia (±0 reports). Lead species Dog (10). Lead co-reported drug Bedinvetmab (5).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 10

Breeds Most Affected

Retriever - Golden 2

Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 1

Collie - Border 1

Bulldog - English 1

Shepherd Dog - German 1

Dog (unknown) 1

Mastiff (unspecified) 1

Hound - Basset 1

Poodle - Miniature 1

Associated Drugs

Bedinvetmab 5

Gabapentin 2

Carprofen 2

Ivermectin + Pyrantel As Pamoate Salt 1

Phenylpropropanolamine Hcl 1

Lotilaner 1

Ivermectin/Pyrantel 1

Milbemycin Oxime + Praziquantel 1

Moxidectin 1

Glycoflex 1

Amoxicillin 1

Oclacitinib Maleate 1

Trazodone 1

What to do with this reaction

Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
Browse the full reaction directory to compare report counts across reaction types. All reactions

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Urinary tract neoplasm NOS (#2481 of 2,481 by report volume); death-coded 30.0%. PlainBreed reaction plate · report volume stamp 10 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →